Crescentis Capital Reports Strong Q3FY26 Turnaround with ₹119.27 Lakhs Profit
Crescentis Capital Limited announced strong Q3FY26 results with profit of ₹119.27 lakhs compared to previous year's loss of ₹428.65 lakhs, demonstrating significant operational turnaround. The company achieved nine-month profit of ₹482.51 lakhs and successfully commenced lending operations while fully utilizing funds from its oversubscribed Rights Issue.

*this image is generated using AI for illustrative purposes only.
Crescentis Capital Limited (formerly known as Som Datt Finance Corporation Limited) announced its Q3FY26 financial results on February 13, 2026, marking a significant turnaround with a profit of ₹119.27 lakhs compared to a loss of ₹428.65 lakhs in the corresponding quarter of the previous year. The board meeting, which was scheduled through a regulatory filing dated February 7, 2026, concluded successfully with the approval of unaudited financial results and key strategic initiatives.
Financial Performance Overview
The company's financial performance for Q3FY26 demonstrates a remarkable recovery across key metrics:
| Metric: | Q3FY26 | Q3FY25 | Change |
|---|---|---|---|
| Total Revenue: | ₹371.95 lakhs | ₹(426.76) lakhs | Significant improvement |
| Net Profit: | ₹119.27 lakhs | ₹(428.65) lakhs | Turnaround to profit |
| Basic EPS: | ₹1.42 | ₹(3.54) | Positive swing |
| Total Expenses: | ₹145.22 lakhs | ₹85.20 lakhs | ₹60.02 lakhs increase |
Nine-Month Performance Highlights
For the nine months ended December 31, 2025, Crescentis Capital achieved substantial growth:
| Parameter: | 9M FY26 | 9M FY25 | Performance |
|---|---|---|---|
| Total Revenue: | ₹892.76 lakhs | ₹70.50 lakhs | 12.7x growth |
| Net Profit: | ₹482.51 lakhs | ₹(164.35) lakhs | Profit turnaround |
| Basic EPS: | ₹3.05 | ₹(1.36) | Positive transformation |
Revenue Composition and Growth Drivers
The company's revenue structure for Q3FY26 showed diversified income streams. Interest income contributed ₹140.04 lakhs, marking the company's entry into active lending operations. Dividend income remained stable at ₹10.91 lakhs compared to ₹5.46 lakhs in Q3FY25. Net gain on fair value changes contributed significantly with ₹221.00 lakhs, reversing the previous year's loss of ₹432.22 lakhs in the same category.
Board Decisions and Strategic Initiatives
The board meeting held on February 13, 2026, from 4:00 PM to 5:10 PM, addressed several key agenda items:
| Decision Area: | Details |
|---|---|
| Financial Results: | Approved Q3FY26 and nine-month unaudited results |
| ESOS Approval: | Approved CCL ESOS 2025 terms and conditions |
| Compliance: | Maintained regulatory adherence under SEBI LODR |
The Nomination and Remuneration Committee recommended the approval of CCL Employees' Stock Option Scheme 2025, which was subsequently approved by the board in accordance with Section 62 of the Companies Act, 2013, and SEBI regulations.
Operational Developments and Fund Utilization
Crescentis Capital successfully commenced its lending operations during the current financial year from June 2025. The company has fully utilized the ₹4,903.91 lakhs raised through its oversubscribed Rights Issue, which closed in July 2025 with 123% oversubscription. The funds were allocated toward augmenting capital base (₹4,745.34 lakhs), general corporate purposes (₹102.01 lakhs), and issue-related expenses (₹56.56 lakhs).
The company operates as a Non-Banking Financial Company with financing and investment activities as its primary business segment. With pledged securities worth ₹2,045.30 lakhs as collateral for loan facilities, Crescentis Capital has strengthened its operational foundation for sustained growth in the NBFC sector.
Historical Stock Returns for Crescentis Capital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.97% | -7.67% | +11.60% | -2.98% | +63.93% | +869.47% |




























